文献速递中医内科针灸推拿中药与中成药合理使用

中药与针灸对失眠共病慢性疼痛的跨诊断治疗作用:范围综述

Exploring the potential transdiagnostic treatment effects of Chinese herbal medicine and acupuncture on insomnia disorder comorbid with chronic pain: A scoping review.
PubMed 文献 · Integr Med Res · 2025-07-29

结果显示中药(改良归脾汤)与针灸在改善失眠和疼痛方面呈中到大效应量,但83.33%研究存在高偏倚风险,结论需谨慎解读。

要点

  • 中药(改良归脾汤)对比地西泮/艾司唑仑,失眠d=0.70-1.17,疼痛d=0.67-1.42。
  • 针灸对比常规治疗,失眠d=0.64-0.99,疼痛d=0.80-1.33。
  • 中药(大活络胶囊)联合针灸对比多药/牵引,失眠d=0.72,疼痛d=0.57。

核心结论

  • 中药与针灸对失眠共病慢性疼痛显示出治疗潜力,但高偏倚风险限制结论可靠性,需高质量RCT进一步验证。

主要发现

  • 中药(改良归脾汤)对比地西泮/艾司唑仑,失眠效应量d=0.70-1.17,疼痛d=0.67-1.42。
  • 针灸对比常规治疗,失眠效应量d=0.64-0.99,疼痛d=0.80-1.33。
  • 中药(大活络胶囊)联合针灸对比多药/牵引,失眠d=0.72,疼痛d=0.57。
  • 83.33%的研究存在高偏倚风险。

关键数值与推荐

  • 纳入标准:成人(≥18岁),DSM-5定义的失眠和IASP定义的慢性疼痛,接受中药或针灸治疗的RCT。
  • 效应量采用改良Cohen's d评估,偏倚风险采用Cochrane Risk of Bias 2工具评估。

临床怎么用

  • 中药和针灸可作为失眠共病慢性疼痛的潜在辅助治疗选择,但需结合高偏倚风险谨慎决策。

局限性

  • 纳入研究数量少(6项RCT),多数研究存在高偏倚风险(83.33%),证据质量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over 20 % of adults with insomnia disorder also experience chronic pain, termed insomnia disorder comorbid with chronic pain (ICCP), increasing risks for physical and mental diseases. Current treatments like cognitive behavioral therapy for insomnia show inconsistent pain relief, and non-opioid analgesics may exacerbate insomnia, underscoring the need for alternative approaches. Chinese herbal medicine (CHM) and acupuncture, guided by traditional Chinese medicine, may offer transdiagnostic benefits for ICCP, but a comprehensive review is lacking. This scoping review evaluates their therapeutic effects and mechanisms for ICCP. METHODS: PubMed, Wanfang, ClinicalTrials.gov and Google Scholar were searched up to December 31, 2024, for randomized controlled trials (RCTs) involving adults (≥18 years) with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition-defined insomnia and the International Association for the Study of Pain-defined chronic pain, treated with CHM or acupuncture. Effect sizes (modified Cohen's d) assessed efficacy of interventions, and the Cochrane Risk of Bias 2 tool evaluated the risk of bias. RESULTS: Six RCTs (487 participants) were included. CHM (modified Guipi decoction) showed medium to large effects for insomnia (d = 0.70-1.17) and pain (d = 0.67-1.42) versus diazepam/estazolam. Acupuncture had medium to large effects for insomnia (d = 0.64-0.99) and pain (d = 0.80-1.33) compared to treatment as usual. Combined CHM (Da Huoluo capsules) and acupuncture showed medium effects (d = 0.72 for insomnia; d = 0.57 for pain) versus multi-medications/traction. Most studies (83.33 %) had high risk of bias. CONCLUSION: CHM and acupuncture show promise for ICCP management, but high risk of bias warrants cautious interpretation and further high-quality RCTs.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Kwok YL, Wang R, Tang HT, et al. Exploring the potential transdiagnostic treatment effects of Chinese herbal medicine and acupuncture on insomnia disorder comorbid with chronic pain: A scoping review. Integr Med Res. 2025. PMID: 40896345. doi:10.1016/j.imr.2025.101208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。